FDA Inspection
Safrel Pharmaceuticals LLCSafrel Pharmaceuticals LLC – FDA Inspection, Jan 30, 2026
Record Details
This FDA Inspection record concerns Safrel Pharmaceuticals LLC, with an inspection on January 30, 2026, issued by the New Jersey District Office, covering foods & cosmetics.
View Company Profile
ID · b8d841fd-8b95-4168-ae4f-a4520cc73dbd
Inspection Facts
- Inspection number
- 1300468
- FDA center
- Foods & Cosmetics
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 111.103Written procedures - establish; quality control operations
- 21 CFR 111.455(a)Hold - temperature, humidity, light
- 21 CFR 111.475(b)Records - written procedures holding and distribution; product distribution
- 21 CFR 111.535(b)Make and keep records - returned dietary supplements
- 21 CFR 111.553Written procedures - establish; product complaint
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.150(b)Distribution Recall System
- 21 CFR 211.180(c)Records not made readily available to FDA
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.